Literature DB >> 18604452

Quality control of the proteins associated with neurodegenerative diseases.

Xuechao Gao1, Hongyu Hu.   

Abstract

Most neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease and other polyglutamine diseases are associated with degeneration and death of specific neuronal populations due to misfolding or aggregation of certain proteins. These aggregates often contain ubiquitin that is the signal for proteolysis by the ubiquitin-proteasome system, and chaperone proteins that are involved in the assistance of protein folding. Here we review the role of protein quality control systems in the pathogenesis of neurodegenerative diseases, and aim to learn more from the cooperation between molecular chaperones and ubiquitin-proteasome system responding to cellular protein aggregates, in order to find molecular targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604452     DOI: 10.1111/j.1745-7270.2008.00441.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  10 in total

1.  Expression profile of HSP genes during different seasons in goats (Capra hircus).

Authors:  Satyaveer Singh Dangi; Mahesh Gupta; Divakar Maurya; Vijay Prakash Yadav; Rudra Prasanna Panda; Gyanendra Singh; Nitai Haridas Mohan; Sanjeev Kumar Bhure; Bikash Chandra Das; Sadhan Bag; Ramkrishna Mahapatra; Guttalu Taru Sharma; Mihir Sarkar
Journal:  Trop Anim Health Prod       Date:  2012-04-26       Impact factor: 1.559

Review 2.  Misfolded proteins recognition strategies of E3 ubiquitin ligases and neurodegenerative diseases.

Authors:  Deepak Chhangani; Nihar Ranjan Jana; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-09-22       Impact factor: 5.590

3.  Charge-rich regions modulate the anti-aggregation activity of Hsp90.

Authors:  Natalie Wayne; Daniel N Bolon
Journal:  J Mol Biol       Date:  2010-07-06       Impact factor: 5.469

4.  Co-chaperone HSJ1a dually regulates the proteasomal degradation of ataxin-3.

Authors:  Xue-Chao Gao; Chen-Jie Zhou; Zi-Ren Zhou; Yu-Hang Zhang; Xue-Ming Zheng; Ai-Xin Song; Hong-Yu Hu
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

Review 5.  Proteostasis and Mitochondrial Role on Psychiatric and Neurodegenerative Disorders: Current Perspectives.

Authors:  Pablo Olivero; Carlo Lozano; Ramón Sotomayor-Zárate; Nicolás Meza-Concha; Marcelo Arancibia; Claudio Córdova; Wilfredo González-Arriagada; Ricardo Ramírez-Barrantes; Ivanny Marchant
Journal:  Neural Plast       Date:  2018-06-27       Impact factor: 3.599

6.  PolyQ-expanded proteins impair cellular proteostasis of ataxin-3 through sequestering the co-chaperone HSJ1 into aggregates.

Authors:  Hong-Wei Yue; Jun-Ye Hong; Shu-Xian Zhang; Lei-Lei Jiang; Hong-Yu Hu
Journal:  Sci Rep       Date:  2021-04-09       Impact factor: 4.379

7.  Extracellular calcium alters calcium-sensing receptor network integrating intracellular calcium-signaling and related key pathway.

Authors:  Rakshya Gorkhali; Li Tian; Bin Dong; Pritha Bagchi; Xiaonan Deng; Shrikant Pawar; Duc Duong; Ning Fang; Nicholas Seyfried; Jenny Yang
Journal:  Sci Rep       Date:  2021-10-18       Impact factor: 4.379

Review 8.  PINK1 function in health and disease.

Authors:  Emma Deas; Helene Plun-Favreau; Nicholas W Wood
Journal:  EMBO Mol Med       Date:  2009-06       Impact factor: 12.137

9.  Cytoplasmic Ubiquitin-Specific Protease 19 (USP19) Modulates Aggregation of Polyglutamine-Expanded Ataxin-3 and Huntingtin through the HSP90 Chaperone.

Authors:  Wen-Tian He; Xue-Ming Zheng; Yu-Hang Zhang; Yong-Guang Gao; Ai-Xin Song; Françoise Gisou van der Goot; Hong-Yu Hu
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

Review 10.  The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.

Authors:  Kundlik Gadhave; Nityanand Bolshette; Ashutosh Ahire; Rohit Pardeshi; Krishan Thakur; Cristiana Trandafir; Alexandru Istrate; Sahabuddin Ahmed; Mangala Lahkar; Dafin F Muresanu; Maria Balea
Journal:  J Cell Mol Med       Date:  2016-03-29       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.